Found 553 bookmarks
Newest
A novel deterioration prediction system for mild COVID-19 patients in Korea: a retrospective study
A novel deterioration prediction system for mild COVID-19 patients in Korea: a retrospective study

Korean study: a scoring system to predict deterioration in mild COVID-19 patients. “A novel scoring system was proposed for predicting the deterioration of patients whose condition may worsen rapidly and those who all still mild or asymptomatic.”

Using data from 954 patients, the system outperformed existing methods with 89.9% accuracy in external validation.

·nature.com·
A novel deterioration prediction system for mild COVID-19 patients in Korea: a retrospective study
Summer COVID surge shows we may have to return to 2020 pandemic measures
Summer COVID surge shows we may have to return to 2020 pandemic measures

“So where do we realistically go from here, given that it is clear that COVD-19 is far from over? While much progress has been made in terms of vaccination and treatment, the current surge is a stark reminder that complacency is not an option. The road ahead will require a renewed commitment to public health, both from government leaders and from individuals. We all need to prepare for not only the possibility of continued disruptions but for another new normal that might be a little closer to 2020 than how we’ve recently been living.”

·thehill.com·
Summer COVID surge shows we may have to return to 2020 pandemic measures
New data shows long Covid is keeping as many as 4 million people out of work
New data shows long Covid is keeping as many as 4 million people out of work

Approximately 16 million working-age Americans (aged 18 to 65) have long Covid today.

Of those, 2 to 4 million are out of work due to long Covid.

The annual cost of those lost wages alone is around $170 billion a year (potentially as high as $230 billion).

Not. The. Flu. Not. Mild. NOT. OVER.

Actually, Democrats, Covid DOES continue to rule our lives.

·brookings.edu·
New data shows long Covid is keeping as many as 4 million people out of work
Findings Associated with Prolonged COVID-19 Recovery among... : Journal of Occupational and Environmental Medicine
Findings Associated with Prolonged COVID-19 Recovery among... : Journal of Occupational and Environmental Medicine

Massachusetts study of 280 healthcare workers 3 years post-Covid: 73.4% with Long Covid reported worse quality of life, depression, anxiety, & stress.

Fear of Covid reinfection similar between groups.

Support needed.

·journals.lww.com·
Findings Associated with Prolonged COVID-19 Recovery among... : Journal of Occupational and Environmental Medicine
Long COVID among healthcare workers: a narrative review of definitions, prevalence, symptoms, risk factors and impacts | British Medical Bulletin | Oxford Academic
Long COVID among healthcare workers: a narrative review of definitions, prevalence, symptoms, risk factors and impacts | British Medical Bulletin | Oxford Academic

The impact on our healthcare workforce is immense, occurring at the same time the general population needs our help more as they too are sickened and disabled by long-covid and post-covid conditions.

in a review of 56 literature studies: Long Covid is “prevalent" among Health Care workers who become infected by SARS-CoV-2

·academic.oup.com·
Long COVID among healthcare workers: a narrative review of definitions, prevalence, symptoms, risk factors and impacts | British Medical Bulletin | Oxford Academic
Patient-Reported Experiences of Persistent Post–COVID-19 Conditions After Hospital Discharge During the Second and Third Waves of the Pandemic in Switzerland: Cross-Sectional Questionnaire Study
Patient-Reported Experiences of Persistent Post–COVID-19 Conditions After Hospital Discharge During the Second and Third Waves of the Pandemic in Switzerland: Cross-Sectional Questionnaire Study

“Study from Switzerland: 245 COVID-19 patients surveyed 4 months post-hospital discharge.

Only 28.2% were symptom-free.

Women and those with longer hospital stays reported more persistent symptoms.

76.4% had memory and concentration issues.

·publichealth.jmir.org·
Patient-Reported Experiences of Persistent Post–COVID-19 Conditions After Hospital Discharge During the Second and Third Waves of the Pandemic in Switzerland: Cross-Sectional Questionnaire Study
COVID can cause new health problems even 3 years after infection, study finds: 'We don’t know what’s going to happen at 10 years'
COVID can cause new health problems even 3 years after infection, study finds: 'We don’t know what’s going to happen at 10 years'
“People are developing new-onset disease as the result of an infection that they had three years ago,” says Dr. Ziyad Al-Aly, a clinical epidemiologist at Washington University in St. Louis and lead author of the study. ‘It challenges the notion that these viruses are sort of self-contained or that after the acute first phase, they become inconsequential.’”
·fortune.com·
COVID can cause new health problems even 3 years after infection, study finds: 'We don’t know what’s going to happen at 10 years'
The Plan to Stop Every Respiratory Virus at Once
The Plan to Stop Every Respiratory Virus at Once

“The Plan to Stop Every Respiratory Virus at Once The benefits of ventilation reach far beyond the coronavirus. What if we stop taking colds and flus for granted, too?”

·theatlantic.com·
The Plan to Stop Every Respiratory Virus at Once
Military Pilots Reported 1,700% More Medical Incidents During the Pandemic. The Pentagon Says They Just Had COVID | Military.com
Military Pilots Reported 1,700% More Medical Incidents During the Pandemic. The Pentagon Says They Just Had COVID | Military.com
February 2023: “The number of medical events that triggered official reporting requirements among U.S. military pilots rose more than 1,700% from 2019 to 2022, an increase the Pentagon says was the result of COVID.”
·military.com·
Military Pilots Reported 1,700% More Medical Incidents During the Pandemic. The Pentagon Says They Just Had COVID | Military.com
Dr. Amer, Ohio State Univ. on IPM today, "I got COVID three times...after the second time, I suffered from brain fog..it was the most horiftying experience of my life. This was very scary..my job depends on my brain. All of a sudden I couldn't even type...it was really shocking."
Dr. Amer, Ohio State Univ. on IPM today, "I got COVID three times...after the second time, I suffered from brain fog..it was the most horiftying experience of my life. This was very scary..my job depends on my brain. All of a sudden I couldn't even type...it was really shocking."
·x.com·
Dr. Amer, Ohio State Univ. on IPM today, "I got COVID three times...after the second time, I suffered from brain fog..it was the most horiftying experience of my life. This was very scary..my job depends on my brain. All of a sudden I couldn't even type...it was really shocking."
FDA Could Soon Limit Use of Only Drug for COVID Prevention
FDA Could Soon Limit Use of Only Drug for COVID Prevention
Pemivibart (Pemgarda) should only be used for pre-exposure prophylaxis of COVID-19 in immunocompromised patients when the combined national frequency of SARS-CoV-2 variants with substantially reduced susceptibility to the drug is less than or equal to 90%, the FDA announced on Monday.
Pemivibart (Pemgarda) should only be used for pre-exposure prophylaxis of COVID-19 in immunocompromised patients when the combined national frequency of SARS-CoV-2 variants with substantially reduced susceptibility to the drug is less than or equal to 90%, the FDA announced on Monday.
·medpagetoday.com·
FDA Could Soon Limit Use of Only Drug for COVID Prevention
Tam 32 431
Tam 32 431

April 2024: 'Long-Term Effects of COVID-19: The Stories of 2 Physicians Who Became Patients'

'James Mwangi, MD; Jeffrey N. Siegelman, MD - Emory Univ. School of Medicine'

'Our intention in this article is to generate more awareness about long COVID...'

·ncbi.nlm.nih.gov·
Tam 32 431
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry | mSphere
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry | mSphere

Study: How SARS-CoV-2 is adapting to better infect people. This study found that the newer Omicron subvariants can replicate better in human cells compared to earlier Omicron strains.

"SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry"

·journals.asm.org·
SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry | mSphere
So we are approaching the field hospital & freezer trucks stage. Good thing covid is over. Couldn't have gotten here without complete failure of societal leadership. Shoutout to everyone just following orders & the people giving zero fucks about walking around sick & maskless.
So we are approaching the field hospital & freezer trucks stage. Good thing covid is over. Couldn't have gotten here without complete failure of societal leadership. Shoutout to everyone just following orders & the people giving zero fucks about walking around sick & maskless.
·x.com·
So we are approaching the field hospital & freezer trucks stage. Good thing covid is over. Couldn't have gotten here without complete failure of societal leadership. Shoutout to everyone just following orders & the people giving zero fucks about walking around sick & maskless.
Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in an Exploratory Analysis from Ongoing CANOPY Phase 3 Clinical Trial | Invivyd
Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in an Exploratory Analysis from Ongoing CANOPY Phase 3 Clinical Trial | Invivyd
PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in Exploratory Analysis Ongoing Phase 3 Clinical Trial May be useful for PRE-EXPOSURE PROPHYLAXIS (Prep) in immunocompromised & immunocompetent
·investors.invivyd.com·
Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in an Exploratory Analysis from Ongoing CANOPY Phase 3 Clinical Trial | Invivyd
“Getting Covid was worth it!” I was disabled by my 2020 Covid infection, mostly bed-bound for two years, then I was reinfected in 2022. My driver’s license expired “during the pandemic,” & NYS made me take a class & a road test. I failed the road test due to my Covid-affected…
“Getting Covid was worth it!” I was disabled by my 2020 Covid infection, mostly bed-bound for two years, then I was reinfected in 2022. My driver’s license expired “during the pandemic,” & NYS made me take a class & a road test. I failed the road test due to my Covid-affected…
·x.com·
“Getting Covid was worth it!” I was disabled by my 2020 Covid infection, mostly bed-bound for two years, then I was reinfected in 2022. My driver’s license expired “during the pandemic,” & NYS made me take a class & a road test. I failed the road test due to my Covid-affected…